$1.1M
+$1.1M this year1 filing since 2026 · latest Other filed
OpZira, Inc. is an ophthalmic medical device company headquartered in Middletown, Pennsylvania, established on September 3, 2025. It was formed when Alcon acquired LumiThera and its Valeda Light Delivery System and LumiThera's diagnostic product lines were spun off to LumiThera shareholders as a standalone company. OpZira sells devices for the early detection and ongoing monitoring of ocular disease, on the premise that earlier detection enables interventions that may slow disease progression. It is led by Clark E. Tedford, PhD, formerly president, CEO and co-founder of LumiThera.
What sets it apart
Carries two already-commercialized ophthalmic diagnostic platforms out of LumiThera: a portable, AI-assisted wearable dark adaptometer that removes the need for a dedicated darkroom, and a combined VEP/ERG system that assesses the neuro-visual pathway as well as the retina.
A wearable dark adaptometer headset with built-in AI and eye-tracking that measures how long the retina takes to adapt after light exposure, a functional marker used in assessing retinal health.
